Inactive Matrix Gla Protein, Arterial Stiffness, and Endothelial Function in African American Hemodialysis Patients

Area of Science:

• Cardiovascular Health
• Nephrology
• Nutritional Biochemistry

Background:

• Matrix Gla protein (MGP) is a vitamin K-dependent inhibitor of vascular calcification.
• Elevated inactive MGP (dp-ucMGP) suggests poor vitamin K status and is linked to cardiovascular disease (CVD) risk.
• African Americans face disproportionately high rates of kidney failure and CVD, yet dp-ucMGP associations remain understudied in this group.

Purpose of the Study:

• To compare vascular vitamin K status, measured by plasma dp-ucMGP, between African American hemodialysis (HD) patients and healthy controls.
• To examine the relationship between dp-ucMGP and markers of arterial stiffness and endothelial function in African American HD patients.

Main Methods:

• Plasma dp-ucMGP levels were measured in 37 African American HD patients and 37 matched controls using enzyme immunoassay.
• Arterial stiffness was assessed via carotid-femoral pulse wave velocity (PWV).
• Endothelial function was measured using brachial artery flow-mediated dilation (FMD) in HD patients.

Main Results:

• HD patients exhibited 5.6 times higher mean dp-ucMGP levels compared to controls (2,139 vs. 382 pmol/l, P < 0.01).
• Higher dp-ucMGP was independently associated with increased arterial stiffness (PWV, standardized β = 0.49, P < 0.01).
• Higher dp-ucMGP was also independently associated with impaired endothelial function (FMD, standardized β = -0.53, P < 0.01).

Conclusions:

• African American hemodialysis patients demonstrate significantly poorer vascular vitamin K status, evidenced by elevated dp-ucMGP.
• This impaired vitamin K status is associated with detrimental vascular changes, including increased arterial stiffness and endothelial dysfunction.
• Findings highlight a potential link between vitamin K deficiency and CVD risk in this high-risk population.